Contact your GP or prescriber promptly if you experience: Diarrhoea lasting more than 4872 hours without improvement Signs of dehydration, including dark urine, dizziness, dry mouth, or reduced urination dehydration can lead to acute kidney injury, particularly in people with pre-existing kidney conditions Blood or mucus in your stools, or rectal bleeding Severe or worsening abdominal pain, particularly if localised, persistent, or accompanied by fever Persistent vomiting that prevents you from keeping fluids down Rapid, symptomatic, or disproportionate weight loss accompanied by systemic symptoms such as fatigue or fever this is distinct from the expected gradual weight loss associated with treatment and should be discussed with your prescriber Symptoms that are substantially affecting your ability to work, sleep, eat, or carry out daily activities Seek urgent medical assessment if you develop: Severe, persistent abdominal pain particularly pain radiating to the back which may indicate pancreatitis
Clinical trials have shown that patients using this combination therapy experience not only greater weight loss but also enhanced improvements in their overall metabolic profiles, including reductions in HbA1c levels, which is a key marker of long-term blood sugar control
Not licensed to dispense sterile compounds, and not licensed generally, in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia, or Delaware
Therapeutic strategies to reduce TMAO levels are being studied including antibiotics and targeted molecules [11, 12]
Obesity ranks as one of the most serious public health challenges today
